UNSPSC 51402206: Duloxetine hydrochloride

This classification denotes an antidepressant agent with the molecular formula C18H19NOS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9044SC542W, chemically known as 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one but more generally known as duloxetine hydrochloride, which bears US NIH Compound Identifier 3151. European Medicines Agency schedules Duloxetine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20026.

UNSPSC 51402206 Duloxetine hydrochloride is a Commodity code intended to classify pharmaceutical products, but the recent state and local procurement activity recorded under this code does not align with duloxetine procurement. Seminole County, Florida posted IFB 60459723LAS seeking Naloxone and Safe Drug Deactivation Systems — products unrelated to duloxetine, an antidepressant medication. The code shows little relevant recent activity for the pharmaceutical product its name describes.

The single opportunity on file is Seminole County's June 2026 posting (due July 26, 2023) for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. This procurement does not represent duloxetine buying patterns and suggests a data-entry or taxonomy-assignment error at the sourcing level rather than active state and local demand for duloxetine under this code.